SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001104659-21-090635
Filing Date
2021-07-09
Accepted
2021-07-09 16:02:19
Documents
42

Document Format Files

Seq Description Document Type Size
1 S-1 tm2115679-6_s1.htm S-1 3491851
2 EXHIBIT 3.1 tm2115679d7_ex3-1.htm EX-3.1 162268
3 EXHIBIT 3.2 tm2115679d7_ex3-2.htm EX-3.2 110912
4 EXHIBIT 10.1 tm2115679d7_ex10-1.htm EX-10.1 353050
5 EXHIBIT 10.2 tm2115679d7_ex10-2.htm EX-10.2 83108
6 EXHIBIT 10.3 tm2115679d7_ex10-3.htm EX-10.3 23351
7 EXHIBIT 10.4 tm2115679d7_ex10-4.htm EX-10.4 72150
8 EXHIBIT 10.5 tm2115679d7_ex10-5.htm EX-10.5 131339
9 EXHIBIT 23.1 tm2115679d7_ex23-1.htm EX-23.1 3049
10 GRAPHIC tm2115679d4_ex10-2img001.jpg GRAPHIC 54299
11 GRAPHIC lg_immuneering-4clr.jpg GRAPHIC 19671
12 GRAPHIC tm2115679d1-tbl_cancer4c.jpg GRAPHIC 215156
13 GRAPHIC tm2115679d3-lc_dynamics4c.jpg GRAPHIC 122787
14 GRAPHIC tm2115679d3-fc_oncology4c.jpg GRAPHIC 111677
15 GRAPHIC tm2115679d1-tbl_phospho4clr.jpg GRAPHIC 121340
16 GRAPHIC tm2115679d1-fc_prop4c.jpg GRAPHIC 185888
17 GRAPHIC tm2115679d3-tbl_target4c.jpg GRAPHIC 174053
18 GRAPHIC tm2115679d3-fc_discover4c.jpg GRAPHIC 31515
19 GRAPHIC tm2115679d1-fc_highly4c.jpg GRAPHIC 82656
20 GRAPHIC tm2115679d1-bc_tumor4c.jpg GRAPHIC 153144
21 GRAPHIC tm2115679d1-bc_comparisn4c.jpg GRAPHIC 99734
22 GRAPHIC tm2115679d1-lc_selumet4c.jpg GRAPHIC 157377
23 GRAPHIC tm2115679d1-lc_immbini4c.jpg GRAPHIC 175542
24 GRAPHIC tm2115679d1-lc_imm1bin4c.jpg GRAPHIC 169435
25 GRAPHIC tm2115679d3-lc_amg4c.jpg GRAPHIC 83962
26 GRAPHIC tm2115679d3-lc_imm4c.jpg GRAPHIC 156791
27 GRAPHIC tm2115679d3-lc_immamg4c.jpg GRAPHIC 114257
28 GRAPHIC tm2115679d3-lc_gemcitab4clr.jpg GRAPHIC 92941
29 GRAPHIC tm2115679d3-bc_pancreat4c.jpg GRAPHIC 128728
30 GRAPHIC tm2115679d3-bc_melanoma4c.jpg GRAPHIC 137448
31 GRAPHIC tm2115679d1-tbl_a549tum4c.jpg GRAPHIC 123056
32 GRAPHIC tm2115679d1-tbl_a375tum4c.jpg GRAPHIC 62168
33 GRAPHIC tm2115679d1-fc_brain4clr.jpg GRAPHIC 144286
34 GRAPHIC tm2115679d1-fc_recursi4clr.jpg GRAPHIC 77845
35 GRAPHIC tm2115679d3-tbl_neurosci4c.jpg GRAPHIC 43602
36 GRAPHIC tm2115679d1-bc_vitro4c.jpg GRAPHIC 46704
37 GRAPHIC tm2115679d1-bc_fluency4c.jpg GRAPHIC 68969
38 GRAPHIC tm2115679d1-bc_micro4c.jpg GRAPHIC 89658
39 GRAPHIC tm2115679d1-lc_gene4c.jpg GRAPHIC 125372
40 GRAPHIC tm2115679d1-fc_compou4clr.jpg GRAPHIC 64521
41 GRAPHIC tm2115679d1-ph_fluen4clr.jpg GRAPHIC 109540
42 GRAPHIC tm2115679d1-lc_erbb24c.jpg GRAPHIC 103071
  Complete submission text file 0001104659-21-090635.txt   9452626
Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-257791 | Film No.: 211082867
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences